Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Nova Measuring Instruments Ltd is a semiconductor equipment & materials business based in the US. Nova Measuring Instruments shares (NVMI) are listed on the NASDAQ and all prices are listed in US Dollars. Nova Measuring Instruments employs 713 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$103.47|
|52-week range||$54.72 - $110.29|
|50-day moving average||$102.35|
|200-day moving average||$97.98|
|Wall St. target price||$114.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.32|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.35%|
|1 month (2021-09-24)||-5.61%|
|3 months (2021-07-23)||6.14%|
|6 months (2021-04-23)||6.36%|
|1 year (2020-10-23)||80.01%|
|2 years (2019-10-24)||198.18%|
|3 years (2018-10-24)||377.04%|
|5 years (2016-10-24)||744.65%|
Valuing Nova Measuring Instruments stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nova Measuring Instruments's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nova Measuring Instruments's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Nova Measuring Instruments shares trade at around 45x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Nova Measuring Instruments's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $88 million.
The EBITDA is a measure of a Nova Measuring Instruments's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$327.7 million|
|Operating margin TTM||24.21%|
|Gross profit TTM||$152.9 million|
|Return on assets TTM||8.7%|
|Return on equity TTM||18.12%|
|Market capitalisation||$2.9 billion|
TTM: trailing 12 months
There are currently 927,105 Nova Measuring Instruments shares held short by investors – that's known as Nova Measuring Instruments's "short interest". This figure is 8.9% up from 851,614 last month.
There are a few different ways that this level of interest in shorting Nova Measuring Instruments shares can be evaluated.
Nova Measuring Instruments's "short interest ratio" (SIR) is the quantity of Nova Measuring Instruments shares currently shorted divided by the average quantity of Nova Measuring Instruments shares traded daily (recently around 80338.388214905). Nova Measuring Instruments's SIR currently stands at 11.54. In other words for every 100,000 Nova Measuring Instruments shares traded daily on the market, roughly 11540 shares are currently held short.
However Nova Measuring Instruments's short interest can also be evaluated against the total number of Nova Measuring Instruments shares, or, against the total number of tradable Nova Measuring Instruments shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nova Measuring Instruments's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Nova Measuring Instruments shares in existence, roughly 30 shares are currently held short) or 0.0328% of the tradable shares (for every 100,000 tradable Nova Measuring Instruments shares, roughly 33 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Nova Measuring Instruments.
Find out more about how you can short Nova Measuring Instruments stock.
We're not expecting Nova Measuring Instruments to pay a dividend over the next 12 months.
Over the last 12 months, Nova Measuring Instruments's shares have ranged in value from as little as $54.72 up to $110.29. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nova Measuring Instruments's is 1.0963. This would suggest that Nova Measuring Instruments's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and material metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, and deposition. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.